DSFIR — DSM-Firmenich AG Income Statement
0.000.00%
Last trade - 00:00
- €28.50bn
- €30.56bn
- €10.63bn
- 12
- 27
- 72
- 27
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS |
Standards: | — | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 11,444 | 8,390 | 10,627 |
Cost of Revenue | |||
Gross Profit | 4,187 | 2,690 | 2,611 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 10,628 | 7,708 | 11,124 |
Operating Profit | 816 | 682 | -497 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 645 | 594 | -647 |
Provision for Income Taxes | |||
Net Income After Taxes | 530 | 470 | -629 |
Minority Interest | |||
Equity in Affiliates | |||
Net Income Before Extraordinary Items | |||
Extraordinary Items | |||
Net Income | 872 | 1,700 | 2,137 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 872 | 1,694 | 2,131 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 5.99 | 3.43 | -0.193 |
Dividends per Share |